Switzerland approves vaccine that targets two Covid variants
Moderna's new Covid-19 vaccine has been given temporary approval in Switzerland.
Copyright 2022 The Associated Press. All Rights Reserved
The Swiss medicaments regulator Swissmedic has given temporary approval for a Covid-19 vaccine from Moderna that has been adapted to give protection against two different strains of the virus.
This content was published on
1 minute
swissinfo.ch/mga
Español
es
Suiza aprueba vacuna contra dos variantes de COVID
The ‘Spikevax Bivalent Original/Omicron’ is designed to be administered in two 0.5ml doses.
It contains 25 micrograms of the original Spikevax mRNA-1273 plus 25 micrograms of a different mRNA that targets the Omicron variant (BA.1 and BA.4/5).
On Monday, Swissmedic saidExternal link that in trials the dual vaccine had achieved higher antibody concentrations against the Omicron variant than the original Spikevax, “with comparable side-effects”.
Those side-effects can include irritation, redness or swelling at the injection site, fatigue, headache, chills or nausea.
The Human Medicines Expert Committee has also given its separate seal of approval for the new vaccine, said Swissmedic.
More
More
Coronavirus: the situation in Switzerland
This content was published on
An overview of the latest Covid-related information in the Alpine nation.
As a Swiss Abroad, how do you feel about the emergence of more conservative family policies in some US states?
In recent years several US states have adopted more conservative policies on family issues, abortion and education. As a Swiss citizen living there, how do you view this development?
Should Switzerland take measures to support its struggling industries?
Industrial policies are back in fashion, not only in the United States but also in the EU. Should Switzerland, where various industries are struggling, draw inspiration from such policies?
Switzerland targets 65% cut in greenhouse gas emissions by 2035
This content was published on
Switzerland has set an ambitious goal to cut its greenhouse gas emissions by at least 65% by 2035, compared to 1990 levels.
Switzerland cuts foreign aid to Albania, Bangladesh and Zambia
This content was published on
This decision comes after the parliament allocated less funding for foreign aid in December than the government had requested.
Switzerland to end international adoptions by 2026
This content was published on
Swiss citizens will no longer be able to adopt children from abroad. The government plans to halt these adoptions to prevent potential abuses.
Home ownership costs in Switzerland up by 2% in 2024
This content was published on
Home ownership in Switzerland became slightly more expensive in 2024. Central Switzerland has the priciest single-family homes at CHF1.78 million.
This content was published on
Six months into his tenure, Vice Chancellor Andrea Arcidiacono said he will leave the Federal Chancellery at the end of March.
Swiss Muslim campaigner faces defamation complaint
This content was published on
The Vaudois Union of Muslim Associations continues its defamation complaint against Saïda Keller-Messahli for her remarks in Le Matin Dimanche.
DRC fighting: UN reports rape and relocates non-essential staff
This content was published on
The UN has moved non-essential staff from Goma in the DRC, after M23 rebels entered on Monday. Reports of rape and looting have emerged.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Switzerland gives green light to Moderna’s Covid vaccine for 6-11 year olds
This content was published on
The Swiss medical regulator Swissmedic has approved Moderna’s Spikevax Covid-19 vaccine for use by children aged 6 to 11 years.
Switzerland approves its first protein-based Covid vaccine
This content was published on
The Swiss medical regulator has approved the Nuvaxovid vaccine for adults making it the fourth Covid-19 vaccine authorised in the country.
Too many Covid doses: Switzerland’s vaccine conundrum
This content was published on
Switzerland is sitting on around 38 million excess Covid-19 vaccine doses to be used by the end of 2022. What will it do with them?
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.